Skip to main content
SpringerLink
Log in
Menu
Find a journal Publish with us Track your research
Search
Cart
  1. Home
  2. Neurotherapeutics
  3. Article

Vagus nerve stimulation for epilepsy and depression

  • Review Article
  • Published: January 2008
  • Volume 5, pages 75–85, (2008)
  • Cite this article
Download PDF
Neurotherapeutics
Vagus nerve stimulation for epilepsy and depression
Download PDF
  • Andrew H. Milby1,
  • Casey H. Halpern1 &
  • Gordon H. Baltuch1 

  • 2152 Accesses

  • 100 Citations

  • 1 Altmetric

  • Explore all metrics

Summary

Many patients with epilepsy suffer from persistent seizures despite maximal antiepileptic drug (AED) therapy. Chronic, intermittent vagus nerve stimulation (VNS) has proven to be a safe, effective option for patients suffering from refractory seizures who are not candidates for surgical resection. Although only a small minority of patients will be entirely seizure-free, VNS as an adjunct to medical therapy does appear to provide a significant amount of improvement in quality of life. Reports of antidepressant effects independent of seizure control, along with the use of multiple AEDs in the treatment of depression, has led to the investigation of VNS as a potential adjunctive treatment for major depressive disorder. Both the number of severely depressed patients refractory to available pharmacologic options and the need for repeated treatments and significant side effects associated with electroconvulsive therapy have heightened the interest in VNS for this patient population. Pilot studies of VNS for depression have shown impressive response rates; however, the effect appears to be gradual in onset, as demonstrated by the lack of a favorable response in a short-term, randomized controlled study. Investigation is thus needed to establish the potential role of VNS as an adjunctive treatment for severe depression.

Article PDF

Download to read the full article text

Similar content being viewed by others

Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review

Article 10 June 2020

Vagus Nerve Stimulation for Intractable Seizures

Chapter © 2013

VNS and Epilepsy

Chapter © 2021
Use our pre-submission checklist

Avoid common mistakes on your manuscript.

References

  1. ILAE Commission on Neurosurgery of Epilepsy. A global survey on epilepsy surgery, 1980–1990: a report by the Commission on Neurosurgery of Epilepsy, the International League Against Epilepsy. Epilepsia 1997;38:249–255.

    Article  Google Scholar 

  2. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314–319.

    Article  CAS  PubMed  Google Scholar 

  3. Terry R, Tarver WB, Zabara J. An implantable neurocybemetic prosthesis system. Epilepsia 1990;31 Suppl 2:S33-S37.

    Article  PubMed  Google Scholar 

  4. Terry RS, Tarver WB, Zabara J. The implantable neurocybemetic prosthesis system. Pacing Clin Electrophysiol 1991;14:86–93.

    Article  CAS  PubMed  Google Scholar 

  5. Reid SA. Surgical technique for implantation of the neurocybernetic prosthesis. Epilepsia 1990;31 Suppl 2: S38-S39.

    Article  PubMed  Google Scholar 

  6. Uthman BM, Wilder BJ, Penry JK, et al. Treatment of epilepsy by stimulation of the vagus nerve. Neurology 1993;43:1338–1345.

    CAS  PubMed  Google Scholar 

  7. Penry JK, Dean JC. Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results. Epilepsia 1990;31 Suppl 2:S40-S43.

    Article  PubMed  Google Scholar 

  8. Landy HJ, Ramsay RE, Slater J, Casiano RR, Morgan R. Vagus nerve stimulation for complex partial seizures: surgical technique, safety, and efficacy. J Neurosurg 1993;78:26–31.

    Article  CAS  PubMed  Google Scholar 

  9. Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol 2002;1:477–482.

    Article  PubMed  Google Scholar 

  10. Shafique S, Dalsing MC. Vagus nerve stimulation therapy for treatment of drug-resistant epilepsy and depression. Perspect Vasc Surg Endovasc Ther 2006;18:323–327; discussion 328.

    Article  PubMed  Google Scholar 

  11. Hancock JC, Hoover DB, Hougland MW. Distribution of muscarinic receptors and acetylcholinesterase in the rat heart. J Auton Nerv Syst 1987;19:59–66.

    Article  CAS  PubMed  Google Scholar 

  12. McGregor A, Wheless J, Baumgartner J, Bettis D. Right-sided vagus nerve stimulation as a treatment for refractory epilepsy in humans. Epilepsia 2005;46:91–96.

    Article  PubMed  Google Scholar 

  13. Tarver WB, George RE, Maschino SE, Holder LK, Wernicke JF. Clinical experience with a helical bipolar stimulating lead. Pacing Clin Electrophysiol 1992;15:1545–1556.

    Article  CAS  PubMed  Google Scholar 

  14. Ali II, Pirzada NA, Kanjwal Y, et al. Complete heart block with ventricular asystole during left vagus nerve stimulation for epilepsy. Epilepsy Behav 2004;5:768–771.

    Article  PubMed  Google Scholar 

  15. George R, Salinsky M, Kuzniecky R, et al.; First International Vagus Nerve Stimulation Study Group. Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. Epilepsia 1994;35:637–643.

    Article  CAS  PubMed  Google Scholar 

  16. Ben-Menachem E, Mañon-Espaillat R, Ristanovic R, et al.; First International Vagus Nerve Stimulation Study Group. Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. Epilepsia 1994;35:616–626.

    Article  CAS  PubMed  Google Scholar 

  17. Henry TR. Therapeutic mechanisms of vagus nerve stimulation. Neurology 2002;59 Suppl 4:S3-S14.

    PubMed  Google Scholar 

  18. Carpenter MB. Core text of neuroanatomy, 4th ed. Baltimore: Williams & Wilkins, 1991.

    Google Scholar 

  19. Steriade M, Contreras D. Relations between cortical and thalamic cellular events during transition from sleep patterns to paroxysmal activity. J Neurosci 1995;15:623–642.

    CAS  PubMed  Google Scholar 

  20. Henry TR, Votaw JR, Pennell PB, et al. Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology 1999;52:1166–1173.

    CAS  PubMed  Google Scholar 

  21. Ben-Menachem E, Hamberger A, Hedner T, et al. Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res 1995;20:221–227.

    Article  CAS  PubMed  Google Scholar 

  22. Hamberger A, Haglid K, Nyström B, Silfvenius H. Co-variation of free amino acids in human epileptogenic cortex. Neurochem Res 1993;18:519–525.

    Article  CAS  PubMed  Google Scholar 

  23. Naritoku DK, Terry WJ, Helfert RH. Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve. Epilepsy Res 1995;22:53–62.

    Article  CAS  PubMed  Google Scholar 

  24. Krahl SE, Clark KB, Smith DC, Browning RA. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 1998;39:709–714.

    Article  CAS  PubMed  Google Scholar 

  25. Meldrum B. Amino acid neurotransmitters and new approaches to anticonvulsant drug action. Epilepsia 1984;25 Suppl 2:S140-S149.

    Article  CAS  PubMed  Google Scholar 

  26. Woodbury DM, Woodbury JW. Effects of vagal stimulation on experimentally induced seizures in rats. Epilepsia 1990;31 Suppl 2:S7-S19.

    Article  PubMed  Google Scholar 

  27. Banzett RB, Guz A, Paydarfar D, Shea SA, Schachter SC, Lansing RW. Cardiorespiratory variables and sensation during stimulation of the left vagus in patients with epilepsy. Epilepsy Res 1999;35: 1–11.

    Article  CAS  PubMed  Google Scholar 

  28. Krahl SE, Senanayake SS, Handforth A. Destruction of peripheral C-fibers does not alter subsequent vagus nerve stimulation-induced seizure suppression in rats. Epilepsia 2001;42:586–589.

    Article  CAS  PubMed  Google Scholar 

  29. Zanchetti A, Wang SC, Moruzzi G. The effect of vagal afferent stimulation on the EEG pattern of the cat. Electroencephalogr Clin Neurophysiol 1952;4:357–361.

    Article  CAS  PubMed  Google Scholar 

  30. Chase MH, Nakamura Y, Clemente CD, Sterman MB. Afferent vagal stimulation: neurographic correlates of induced EEG synchronization and desynchronization. Brain Res 1967;5:236–249.

    Article  CAS  PubMed  Google Scholar 

  31. Schachter SC, Saper CB. Vagus nerve stimulation. Epilepsia 1998;39:677–686.

    Article  CAS  PubMed  Google Scholar 

  32. Koo B. EEG changes with vagus nerve stimulation. J Clin Neurophysiol 2001;18:434–441.

    Article  CAS  PubMed  Google Scholar 

  33. Murphy JV; The Pediatric VNS Study Group. Left vagal nerve stimulation in children with medically refractory epilepsy. J Pediatr 1999; 134:563–566.

    Article  CAS  PubMed  Google Scholar 

  34. Lundgren J, Amark P, Blennow G, Strömblad LG, Wallstedt L. Vagus nerve stimulation in 16 children with refractory epilepsy. Epilepsia 1998;39:809–813.

    Article  CAS  PubMed  Google Scholar 

  35. Vonck K, Boon P, D’Havé M, Vandekerckhove T, O’Connor S, De Reuck J. Long-term results of vagus nerve stimulation in refractory epilepsy. Seizure 1999;8:328–334.

    Article  CAS  PubMed  Google Scholar 

  36. Zabara J. Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia 1992;33: 1005–1012.

    Article  CAS  PubMed  Google Scholar 

  37. Lockard JS, Congdon WC, DuCharme LL. Feasibility and safety of vagal stimulation in monkey model. Epilepsia 1990;31 Suppl 2:S20-S26.

    Article  PubMed  Google Scholar 

  38. Takaya M, Terry WJ, Naritoku DK. Vagus nerve stimulation induces a sustained anticonvulsant effect. Epilepsia 1996;37:1111–1116.

    Article  CAS  PubMed  Google Scholar 

  39. Uthman BM, Wilder BJ, Hammond EJ, Reid SA. Efficacy and safety of vagus nerve stimulation in patients with complex partial seizures. Epilepsia 1990;31 Suppl 2:S44-S50.

    Article  PubMed  Google Scholar 

  40. Wilder BJ, Uthman BM, Hammond EJ. Vagal stimulation for control of complex partial seizures in medically refractory epileptic patients. Pacing Clin Electrophysiol 1991;14:108–115.

    Article  CAS  PubMed  Google Scholar 

  41. Murphy JV, Homig G, Schallert G. Left vagal nerve stimulation in children with refractory epilepsy: preliminary observations. Arch Neurol 1995;52:886–889.

    CAS  PubMed  Google Scholar 

  42. Labar D, Nikolov B, Tarver B, Fraser R. Vagus nerve stimulation for symptomatic generalized epilepsy: a pilot study. Epilepsia 1998;39:201–205.

    Article  CAS  PubMed  Google Scholar 

  43. Boon P, Vonck K, Vandekerckhove T, et al. Vagus nerve stimulation for medically refractory epilepsy; efficacy and cost-benefit analysis. Acta Neurochir (Wien) 1999;141:447–452; discussion 453.

    Article  CAS  Google Scholar 

  44. The Vagus Nerve Stimulation Study Group. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. Neurology 1995;45:224–230.

    Google Scholar 

  45. Handforth A, DeGiorgio CM, Schachter SC, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998;51:48–55.

    CAS  PubMed  Google Scholar 

  46. Tatum WO, Johnson KD, Goff S, Ferreira JA, Vale FL. Vagus nerve stimulation and drug reduction. Neurology 2001;56:561–563.

    CAS  PubMed  Google Scholar 

  47. McLachlan RS, Sadler M, Pillay N, et al. Quality of life after vagus nerve stimulation for intractable epilepsy: is seizure control the only contributing factor? Eur Neurol 2003;50:16–19.

    Article  PubMed  Google Scholar 

  48. Amar AP, DeGiorgio CM, Tarver WB, Apuzzo ML. Long-term multicenter experience with vagus nerve stimulation for intractable partial seizures: results of the XE5 trial. Stereotact Funct Neurosurg 1999;73:104–108.

    Article  CAS  PubMed  Google Scholar 

  49. Salinsky MC, Uthman BM, Ristanovic RK, Wemicke JF, Tarver WB; Vagus Nerve Stimulation Study Group. Vagus nerve stimulation for the treatment of medically intractable seizures: results of a 1-year open-extension trial. Arch Neurol 1996;53:1176–1180.

    CAS  PubMed  Google Scholar 

  50. Morris GL 3rd, Mueller WM; The Vagus Nerve Stimulation Study Group E01-E05. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy [Erratum in: Neurology 2000;54:1712]. Neurology 1999;53:1731–1735.

    PubMed  Google Scholar 

  51. Kawai K, Shimizu H, Maehara T, Murakami H. Outcome of long-term vagus nerve stimulation for intractable epilepsy. Neurol Med Chir (Tokyo) 2002;42:481–489; discussion 490.

    Article  Google Scholar 

  52. Scherrmann J, Hoppe C, Kral T, Schramm J, Elger CE. Vagus nerve stimulation: clinical experience in a large patient series. J Clin Neurophysiol 2001;18:408–414.

    Article  CAS  PubMed  Google Scholar 

  53. Spanaki MV, Allen LS, Mueller WM, Morris GL 3rd. Vagus nerve stimulation therapy: 5-year or greater outcome at a university-based epilepsy center. Seizure 2004;13:587–590.

    Article  PubMed  Google Scholar 

  54. Labar D. Vagus nerve stimulation for 1 year in 269 patients on unchanged antiepileptic drugs. Seizure 2004;13: 392–398.

    Article  PubMed  Google Scholar 

  55. Heck C, Helmers SL, DeGiorgio CM. Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use. Neurology 2002;59 Suppl 4:S31-S37.

    CAS  PubMed  Google Scholar 

  56. Homig GW, Murphy JV, Schallert G, Tilton C. Left vagus nerve stimulation in children with refractory epilepsy: an update. South Med J 1997;90:484–488.

    Google Scholar 

  57. Alexopoulos AV, Kotagal P, Loddenkemper T, Hammel J, Bingaman WE. Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy. Seizure 2006;15:491–503.

    Article  PubMed  Google Scholar 

  58. Hallböök T, Lundgren J, Stjernqvist K, Blennow G, Strömblad LG, Rosen I. Vagus nerve stimulation in 15 children with therapy resistant epilepsy; its impact on cognition, quality of life, behaviour and mood. Seizure 2005;14:504–513.

    Article  PubMed  Google Scholar 

  59. Patwardhan RV, Stong B, Bebin EM, Mathisen J, Grabb PA. Efficacy of vagal nerve stimulation in children with medically refractory epilepsy. Neurosurgery 2000;47:1353–1357; discussion 1357–1358.

    Article  CAS  PubMed  Google Scholar 

  60. Hosain S, Nikalov B, Harden C, Li M, Fraser R, Labar D. Vagus nerve stimulation treatment for Lennox-Gastaut syndrome. J Child Neurol 2000;15:509–512.

    Article  CAS  PubMed  Google Scholar 

  61. Frost M, Gates J, Helmers SL, et al. Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome. Epilepsia 2001;42:1148–1152.

    Article  CAS  PubMed  Google Scholar 

  62. Michaud CM, Murray CJ, Bloom BR. Burden of disease: implications for future research. JAMA 2001;285:535–539.

    Article  CAS  PubMed  Google Scholar 

  63. Kessler RC, Berglund P, Dernier O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095–3105.

    Article  PubMed  Google Scholar 

  64. Vicente B, Kohn R, Rioseco P, Saldivia S, Levav I, Torres S. Lifetime and 12-month prevalence of DSM-III-R disorders in the Chile psychiatric prevalence study. Am J Psychiatry 2006; 163:1362–1370.

    Article  PubMed  Google Scholar 

  65. American Psychiatric Association; American Psychiatric Association. Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders (DSM-IV-TR), 4th ed., text revision. Washington, DC: American Psychiatric Association, 2000.

    Google Scholar 

  66. Thase ME. Treatment of severe depression. J Clin Psychiatry 2000;61 Suppl 1:17–25.

    PubMed  Google Scholar 

  67. Simon GE. Social and economic burden of mood disorders. Biol Psychiatry 2003;54:208–215.

    Article  PubMed  Google Scholar 

  68. Doyle JJ, Casciano J, Arikian S, Tarride JE, Gonzalez MA, Casciano R. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs. Value Health 2001;4:16–31.

    Article  CAS  PubMed  Google Scholar 

  69. Rasmussen KG, Sampson SM, Rummans TA. Electroconvulsive therapy and newer modalities for the treatment of medication-refractory mental illness. Mayo Clin Proc 2002;77:552–556.

    Article  PubMed  Google Scholar 

  70. Prudic J, Olfson M, Marcus SC, Fuller RB, Sackeim HA. Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry 2004;55:301–312.

    Article  PubMed  Google Scholar 

  71. Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 2000;42:203–210.

    Article  CAS  PubMed  Google Scholar 

  72. Rawlins P. Are there benefits, in addition to seizure control, for children receiving vagus nerve stimulation? Epilepsia 1997; 38(Suppl 8):155–156.

    Google Scholar 

  73. Post RM, Ketter TA, Denicoff K, et al. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology (Berl) 1996; 128:115–129.

    Article  CAS  Google Scholar 

  74. Ghaemi SN, Katzow JJ, Desai SP, Goodwin FK. Gabapentin treatment of mood disorders: a preliminary study. J Clin Psychiatry 1998;59:426–429.

    Article  CAS  PubMed  Google Scholar 

  75. O’Reardon JP, Cristancho P, Peshek AD. Vagal nerve stimulation and treatment of depression: to the brainstem and back. Psychiatry 2006;3:54–63.

    PubMed  Google Scholar 

  76. Sackeim HA, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001;25:713–728.

    Article  CAS  PubMed  Google Scholar 

  77. Bohning DE, Lomarev MP, Denslow S, Nahas Z, Shastri A, George MS. Feasibility of vagus nerve stimulation-synchronized blood oxygenation level-dependent functional MRI. Invest Radiol 2001;36: 470–479.

    Article  CAS  PubMed  Google Scholar 

  78. Lomarev M, Denslow S, Nahas Z, Chae JH, George MS, Bohning DE. Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects. J Psychiatr Res 2002;36:219–227.

    Article  PubMed  Google Scholar 

  79. Conway CR, Sheline YI, Chibnall JT, George MS, Fletcher JW, Mintun MA. Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Res 2006;146:179–184.

    Article  PubMed  Google Scholar 

  80. Zobel A, Joe A, Freymann N, et al. Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach. Psychiatry Res 2005;139:165–179.

    Article  PubMed  Google Scholar 

  81. Mayberg HS. Positron emission tomography imaging in depression: a neural systems perspective. Neuroimaging Clin N Am 2003;13:805–815.

    Article  PubMed  Google Scholar 

  82. Krahl SE, Senanayake SS, Pekary AE, Sattin A. Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. J Psychiatr Res 2004;38:237–240.

    Article  PubMed  Google Scholar 

  83. Doit AE, Debonnel G. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J Pharmacol Exp Ther 2006;318:890–898.

    Article  CAS  Google Scholar 

  84. Rush AJ, George MS, Sackeim HA, et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry 2000;47:276–286.

    Article  CAS  PubMed  Google Scholar 

  85. Nahas Z, Marangell LB, Husain MM, et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 2005;66:1097–1104.

    Article  PubMed  Google Scholar 

  86. Marangell LB, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry 2002;51:280–287.

    Article  PubMed  Google Scholar 

  87. George MS, Rush AJ, Marangell LB, et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 2005;58:364–373.

    Article  PubMed  Google Scholar 

  88. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001;285:1299–1307.

    Article  CAS  PubMed  Google Scholar 

  89. Rush AJ, Sackeim HA, Marangell LB, et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 2005;58:355–363.

    Article  PubMed  Google Scholar 

  90. Rush AJ, Marangell LB, Sackeim HA, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005;58:347–354.

    Article  PubMed  Google Scholar 

  91. Smyth MD, Tubbs RS, Bebin EM, Grabb PA, Blount JP. Complications of chronic vagus nerve stimulation for epilepsy in children. J Neurosurg 2003;99:500–503.

    Article  PubMed  Google Scholar 

  92. MacDonald J, Couldwell WT. Revision of vagal nerve stimulator electrodes: technical approach. Acta Neurochir (Wien) 2004;146:567–570; discussion 570.

    Article  CAS  Google Scholar 

  93. Ramsay RE, Uthman BM, Augustinsson LE, et al.; First International Vagus Nerve Stimulation Study Group. Vagus nerve stimulation for treatment of partial seizures: 2. Safety, side effects, and tolerability. Epilepsia 1994;35: 627–636.

    Article  CAS  PubMed  Google Scholar 

  94. Kim W, Clancy RR, Liu GT. Homer syndrome associated with implantation of a vagus nerve stimulator. Am J Ophthalmol 2001; 131:383–384.

    Article  CAS  PubMed  Google Scholar 

  95. Lundy DS, Casiano RR, Landy HJ, Gallo J, Gallo B, Ramsey RE. Effects of vagal nerve stimulation on laryngeal function. J Voice 1993;7:359–364.

    Article  CAS  PubMed  Google Scholar 

  96. Zumsteg D, Jenny D, Wieser HG. Vocal cord adduction during vagus nerve stimulation for treatment of epilepsy. Neurology 2000;54:1388–1389.

    CAS  PubMed  Google Scholar 

  97. Shaffer MJ, Jackson CE, Szabo CA, Simpson CB. Vagal nerve stimulation: clinical and electrophysiological effects on vocal fold function. Ann Otol Rhinol Laryngol 2005;114:7–14.

    PubMed  Google Scholar 

  98. Shaw GY, Sechtem P, Searl J, Dowdy ES. Predictors of laryngeal complications in patients implanted with the Cyberonics vagal nerve stimulator. Ann Otol Rhinol Laryngol 2006;115:260–267.

    PubMed  Google Scholar 

  99. Wakai S, Kotagal P. Vagus nerve stimulation for children and adolescents with intractable epilepsies. Pediatr Int 2001;43:61–65.

    Article  CAS  PubMed  Google Scholar 

  100. Farooqui S, Boswell W, Hemphill JM, Pearlman E. Vagus nerve stimulation in pediatric patients with intractable epilepsy: case series and operative technique. Am Surg 2001;67:119–121.

    CAS  PubMed  Google Scholar 

  101. Majoic HJ, Berfelo MW, Aldenkamp AP, Renier WO, Kessels AG. Vagus nerve stimulation in patients with catastrophic childhood epilepsy, a 2-year follow-up study. Seizure 2005;14:10–18.

    Article  Google Scholar 

  102. Helmers SL, Wheless JW, Frost M, et al. Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: retrospective study. J Child Neurol 2001;16:843–848.

    Article  CAS  PubMed  Google Scholar 

  103. Chavel SM, Westerveld M, Spencer S. Long-term outcome of vagus nerve stimulation for refractory partial epilepsy. Epilepsy Behav 2003;4:302–309.

    Article  PubMed  Google Scholar 

  104. Hui AC, Lam JM, Wong KS, Kay R, Poon WS. Vagus nerve stimulation for refractory epilepsy: long term efficacy and side-effects. Chin Med J (Engl) 2004;117:58–61.

    Google Scholar 

  105. Holmes MD, Silbergeld DL, Drouhard D, Wilensky AJ, Ojemann LM. Effect of vagus nerve stimulation on adults with pharmacoresistant generalized epilepsy syndromes. Seizure 2004;13:340–345.

    Article  PubMed  Google Scholar 

  106. Huf RL, Mamelak A, Kneedy-Cayem K. Vagus nerve stimulation therapy: 2-year prospective open-label study of 40 subjects with refractory epilepsy and low IQ who are living in long-term care facilities. Epilepsy Behav 2005;6:417–423.

    Article  PubMed  Google Scholar 

  107. Rychlicki F, Zamponi N, Trignani R, Ricciuti RA, Iacoangeli M, Scerrati M. Vagus nerve stimulation: clinical experience in drug-resistant pediatric epileptic patients. Seizure 2006;15:483–490.

    Article  PubMed  Google Scholar 

  108. Saneto RP, Sotero de Menezes MA, Ojemann JG, et al. Vagus nerve stimulation for intractable seizures in children. Pediatr Neurol 2006;35:323–326.

    Article  PubMed  Google Scholar 

  109. De Herdt V, Boon P, Ceulemans B, et al. Vagus nerve stimulation for refractory epilepsy: a Belgian multicenter study. Eur J Paediatr Neurol 2007;11:261–269.

    Article  PubMed  Google Scholar 

  110. Kostov H, Larsson PG, Roste GK. Is vagus nerve stimulation a treatment option for patients with drug-resistant idiopathic generalized epilepsy? Acta Neurol Scand Suppl 2007;187:55–58.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Center for Functional and Restorative Neurosurgery, University of Pennsylvania Medical Center, 19104, Philadelphia, Pennsylvania

    Andrew H. Milby, Casey H. Halpern & Gordon H. Baltuch

Authors
  1. Andrew H. Milby
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Casey H. Halpern
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gordon H. Baltuch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gordon H. Baltuch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Milby, A.H., Halpern, C.H. & Baltuch, G.H. Vagus nerve stimulation for epilepsy and depression. Neurotherapeutics 5, 75–85 (2008). https://doi.org/10.1016/j.nurt.2007.10.071

Download citation

  • Issue Date: January 2008

  • DOI: https://doi.org/10.1016/j.nurt.2007.10.071

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Key Words

  • Vagus nerve stimulation
  • vagal
  • epilepsy
  • seizure
  • depression
Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Advertisement

Search

Navigation

  • Find a journal
  • Publish with us
  • Track your research

Discover content

  • Journals A-Z
  • Books A-Z

Publish with us

  • Journal finder
  • Publish your research
  • Open access publishing

Products and services

  • Our products
  • Librarians
  • Societies
  • Partners and advertisers

Our imprints

  • Springer
  • Nature Portfolio
  • BMC
  • Palgrave Macmillan
  • Apress
  • Your US state privacy rights
  • Accessibility statement
  • Terms and conditions
  • Privacy policy
  • Help and support
  • Cancel contracts here

18.207.133.13

Not affiliated

Springer Nature

© 2024 Springer Nature